
Scientist. ICREA Professor @icreacommunity. Single Cell Genomics Group Leader @cnag_eu. @humancellatlas. Barcelona, Spain. Co-founder & CSO @omniscopeAI.
Barcelona, España
Joined December 2012
- Tweets3.1K
- Following612
- Followers5.9K
- Likes5.4K
Pinned Tweet
TICK tock. Your Immune clock is ticking!
-Immune Age- @OmniscopeAI is launching a suite of Immune Tracking products at #MWC2025.
-Immune Age- leverages T cells as a living sensors to sense and memorize systemic challenges. Pathogen exposure, for instance, triggers an immune response that leaves a lasting imprint on the T cell repertoire. However, we found that the signals encoded in T cell receptor (#TCR) sequences extend far beyond infections. They carry quantifiable insights into stress, internal and external load, and, ultimately, biological aging.
@OmniscopeAI, together with @FCBarcelona_es, now applies the potential of T cell sequencing as a Diagnostic tool to define Health, to optimize Performance and to avoid Injuries. Our T Cell Clock is a dynamic measure to quantify the accumulation of a player's load and the success of targeted interventions.
No doubt, our -Immune Age- application will go beyond the area of sports, to better define health and to extend healthy aging (#Healthspan). Our T cell sensor approach provides a new Biomarker strategy to quantify #BiologicalAge, complementing the more static Methylation clocks (@EricTopol : erictopol.substack.com/p/ste…).
Excited to see -Immune Age- to be applied in additional health intervention studies. Please reach out to collaborate! #HealthyAging #Longevity
✨ Honored to step into the role of Vice Co-Chair of the Human Cell Atlas ✨ Working together with our new co-chairs Chloé Villani and Muzz Haniffa, alongside my fellow Vice Co-Chair Shyam Prabhakar.
I can’t imagine a better next leadership team for the @humancellatlas. Beyond their strong track record, it’s a pleasure to work with such thoughtful and collaborative colleagues. This is a particularly meaningful moment for me, having been part of the HCA journey for almost a decade. I have had the privilege of co-chairing the HCA Technology Working Group and Industry Partnership Program, and more recently serving on the HCA 2.0 Task Force, helping shape the vision and strategy for this next phase.
As we move towards HCA 2.0, we are defining the future vision and roadmap for the next generation of the Human Cell Atlas #HCANext10. In my new role, I will specifically focus on leading the HCA technology roadmap, working closely with our technology community as well as biotech and pharma partners to integrate the latest single-cell and spatial technologies into the HCA roadmap. I’m very grateful to the HCA community for the trust. Excited for the next chapter of the Human Cell Atlas and for what we can build together.
@sangerinstitute @broadinstitute @ASTARsg @cnag_eu
When Treatment to #Autoimmune Diseases Fail,
Combining Targeted Therapies Offers a Solution.
NOW OUT @CellRepMed! 👀
We introduced Mitigation of Non-Response Signature (MNRS), a framework that uses longitudinal blood transcriptomic data across 6 IMIDs to systematically rank complementary (and incompatible) drug pairs.
Targeted therapies reshaped how we treat immune-mediated inflammatory diseases (IMIDs), but primary non-response remains a major therapeutic ceiling. Combining treatments is a potential solution, yet prioritizing which drug pairs to test in clinical trials out of thousands of combinations is a massive hurdle.
Key Findings:
- Data-Driven Prioritization: MNRS successfully maps complementary pairs of biologics and small molecules using longitudinal patient data.
- A Winning Pair in RA: In rheumatoid arthritis, combining anti-TNF and anti-IL-6R therapies emerged as highly complementary.
- Mechanism Discovered: Single-cell analysis localized this drug complementarity specifically to CD14+ monocytes.
- In Vivo Validation: In a collagen-induced arthritis mouse model, the anti-TNF + anti-IL-6R combination significantly outperformed monotherapy.
Huge thanks to the entire team DOCTIS Project who made this work possible!
@cnag_eu Centro Nacional de Análisis Genómico (CNAG) @OmniscopeAI @DoctisEU
🔗 Read the full open-access paper here:
cell.com/cell-reports-medici…
osLifetime goes Clinics 👀
Case Report: #Graves’ Orbitopathy (Thyroid Eye Disease) profiling to capture immune shifts as a patient transitioned from non-response under high-dose pulse corticosteroid therapy to clinical remission following an anti-IL-6 receptor therapy (#tocilizumab).
We performed longitudinal Immune tracking for intra-individual baselines definition and to track disease initiation, evolution, and therapeutic response. Our latest preprint shows how osLifetime provides a dynamic view of the immune system for precise patient management.
Key osLifetime insights:
- Autoimmune T-Cell Activity: We tracked dynamic T-cell clonotype expansions to quantify the strength of the autoimmunity, response and relapse.
- Immune Cell States: We captured functional cellular shifts, uncovering therapeutic resistance to steroids before clinical failure manifested.
- Actionable Immune Signatures: We delivered timely, systemic readouts far beyond classical disease-centric serology and routine blood counts.
By moving from static markers to a multimodal, longitudinal immune view, #osLifetime established a scalable framework for personalized management in Graves’ Orbitopathy and other autoimmune diseases.
📄 Read the preprint on SSRN:
papers.ssrn.com/sol3/papers.…
Holger Heyn retweeted
Human Cell Atlas at 10: A Decade of Discovery and the Road to HCA 2.0
@julemieux1 spoke with @hoheyn, @cnag_eu's ICREA professor and @OmniscopeAI co-founder about the meeting and the next 10 years. Heyn has been with the HCA since (almost) the beginning.
hubs.li/Q04tqsW_0
Do you want to know what the next 10 years of the @humancellatlas will look like? #HCANext10 🌍 "Modeling human biology is a hard task. To get there, we will need human data at unprecedented scale, resolution, diversity, and context."
Check out my interview with the wonderful @julemieux1 at
@GENbio to learn more about our vision for the next decade: including our #Spatial and #VirtualCell programs.
The first 10 years of HCA have given us an incredible foundation. Now, it’s time to build the next generation of the Atlas. Exciting times ahead! 🚀
Read the full interview at GEN
genengnews.com/topics/omics/…
#HumanCellAtlas #SingleCell #SpatialBiology #VirtualCell
OUT NOW @Cell_Metabolism ⭐⭐⭐
The Human Pancreas Atlas (EU edition).
Profiling more than 4 million cells and nuclei from 57 donors across fetal development, adult homeostasis, and type 2 diabetes (T2D). Integrating multiple modalities: sc/snRNA-seq, snATAC-seq, VASA-seq, spatial transcriptomics (Xenium) and multiplexed proteomics (CODEX).
It takes a village to build an atlas of the human pancreas. This work has been part of the @humancellatlas project, within the EU-funded #ESPACE project. Thanks to Roland Eils and Elisabetta Mereu for the exceptional leadership. This paper is a major milestone of the Human Cell Atlas, as we move into the HCA2.0 phase, broadening the scope to include human #diversity, #age, #spatial resolution, and #disease.
I am extremely proud to have been part of this endeavor, and I’m excited to move to the next phase of the Human Cell Atlas together with our colleagues and friends across the HCA community.
@cnag_eu @CarrerasIJC and many more.
Please find the paper here:
cell.com/cell-metabolism/ful…
Zooming into Autoimmunity: from Micro to Macro views 🔎 #Autoimmune diseases leave a blueprint hidden inside our immune cells. Our mission is turning these cellular signals into actionable clinical precision tools, from universal solutions to the exact mechanisms driving pathology.
Our vision is captured by two recent publications:
1️⃣ The Micro Focus (@Rheumatology academic.oup.com/rheumatolog…): Translating deep single-cell profiling directly to pediatric autoimmunity. This study unmasked the explicit rogue cells driving Juvenile Idiopathic #Arthritis (oligo JIA) and its severe extra-articular complication, #uveitis. By tracking down clonally expanded, cytotoxic CD8 T cells and transcriptionally reprogrammed MAIT cells, we proved how local joint inflammation and systemic dynamics can be mapped right down to single-cell behavior.
2️⃣ The Macro View (@NatureMedicine; nature.com/articles/s41591-0…): A massive, global atlas profiling 6.5 million cells across 1,047 patients and 19 different conditions. This study used explainable machine learning to map out a universal model of inflammation, proving that circulating immune cells serve as dynamic, living biomarkers to decode how systemic immune-mediated diseases function in the blood.
Blood is a highly accessible, incredibly rich #diagnostic resource. By applying advanced #immunogenomics to track rogue cellular drivers, we aren't just observing autoimmune diseases, we are mapping the exact blueprints to intercept them!
#scienceisweall @OmniscopeAI
#ThrowbackSaturday ☀️
Immune cells in blood are powerful living biomarkers for diseases. Specifically, #autoimmune diseases leave their distinct molecular fingerprints in circulating immune cells.
Hence, blood is an accessible resource, not only as a universal tool for precise patient diagnosis and personalized monitoring, but also as a window to identify autoimmune-driving pathogenic rogue cells.
In our paper published in @NatureMedicine, we leveraged the power of single-cell transcriptomics to build a comprehensive, global model of inflammation. By analyzing a massive single-cell atlas of more than 6.5 million peripheral blood mononuclear cells from 1,047 patients across 19 different diseases, we moved beyond traditional, disease-centered boundaries.
Happy weekend-reading 📒
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
nature.com/articles/s41591-0…
Holger Heyn retweeted
Your most valuable corporate asset isn’t in a bank. It’s the "IQ Compounding" found in your leadership’s health.
In Hong Kong for Longevity in Focus, Vijay shares how Omniscope decodes immune data to capture the Wisdom Dividend.
🤝 eu1.hubs.ly/H0sKJ_H0
#ScienceIsWeAll
Holger Heyn retweeted
Your immune age, recovery, and resilience are uniquely yours. Omniscope builds cellular avatars to model health, performance, & aging in real time.
See it live at Sports Tomorrow Congress, Barcelona | Mar 2–3, 2026:
eu1.hubs.ly/H0s6bzM0
#ScienceIsWeAll #STC26
@BarcaInnoHub
Holger Heyn retweeted
Holger Heyn @hoheyn, del Laboratorio de Genómica de Célula Única del ICREA @cnag_eu @humancellatlas:
🗨️ “Esta técnica podría permitir en un futuro próximo el diseño de tratamientos inmunológicos personalizados”
#medicinapersonalizada #enfermedades #inmunologia
Holger Heyn retweeted
Health isn’t abstract. It’s cellular.
At Omniscope, we decode immune aging cell by cell, turning biology into something measurable, predictable, and actionable.
See what’s next at Sports of Tomorrow Congress, Barcelona | Mar 2–3:
🤝 omniscope.ai/contact?i_m_loo…
#ScienceIsWeAll
Holger Heyn retweeted
#Health isn’t static.
osLifetime tracks immune aging, inflammation, and resilience. Integrating blood data and wearables to reveal how your body is truly responding to #Life and #Time.
Explore osLifetime ➟ eu1.hubs.ly/H0rQ4C50
#ScienceIsWeAll
Holger Heyn retweeted
🗞️A study published in @NatureMedicine and led by #ICREAresearcher Holger Heyn (@hoheyn @cnag_eu) expands the current knowledge of inflammation biology and creates a framework for classifying inflammatory diseases.
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
nature.com/articles/s41591-0…
Holger Heyn retweeted
👏Our congratulations to the #ICREAresearcher (@hoheyn @cnag_eu) co-founder of @OmniscopeAI, on the development of such advances on this platform that make information on the immune system accessible and interactive.
Ladies and gentlemen – Full #ImmuneGPT integration is live 🚀 Talk to your immune system🩸
At #JPM, @Omniscope launched a major milestone: ImmuneGPT is now fully integrated into #osLifetime.
You think the immune system is too complex? That we need more data and better models to crack the immune code? Right — and wrong.
You are right: Immunology is complex.
You are wrong if you think that complexity should stay inaccessible. #ImmuneGPT was built to make complex biology immediately useful. And #osLifetime was built to visualize immune cells as Living Biomarkers🩸, translating deep immune signals into personalized, actionable recommendations — from lifestyle and diet to exercise, supplements, and longitudinal health tracking.
What’s new — and what changes everything:
🔥 Your Cellular Avatar is now interactive
With ImmuneGPT integrated, your immune system comes alive. You can now interact with your personalized cellular profile, ask questions, explore immune states, and understand how choices today shape immune health tomorrow.
Yesterday, Omniscope CEO Vijay Vaswani officially launched this integration, turning advanced immune modeling into something you can actually use.
This is a game changer for actionability:
From immune data → understanding
From understanding → ownership
From ownership → a longer, healthier life
👉 Explore osLifetime here: (lnkd.in/d-KewwHY)
Reach out for full access to ImmuneGPT and personalized profiles!
Your immune system is already talking.
Now you can finally listen — and respond.
🔬 #DocTISProject data featured in @NatureMedicine!
🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators.
🔗 doctis.eu/cellular-inflammat…
#NatureMedicine
Holger Heyn retweeted
This May 10-15 in Les Diablerets, Switzerland, we are bringing cutting-edge research from leaders in single-cell omics and artificial intelligence (AI) to GRC Single-Cell Genomics 2026! If you’re interested, please submit your abstract ASAP! grc.org/single-cell-genomics…
Holger Heyn retweeted
Congrats to the team! We’re happy to have contributed to the Atlas of Human Inflammation, improving the interpretability of inflammatory signatures through inference of transcription factor activity (@8JoseLinares, @roramirezf94 and @JulioSaezRod)
Ladies and gentlemen - Our Atlas of Human Inflammation today out in @NatureMedicine 💫
Welcome on stage: The Cell as a Living Biomarker🩸
We Built an Inflammation Atlas of Circulating Immune Cells. By profiling more than 6.5 million peripheral blood mononuclear cells from 1,047 patients across 19 inflammatory and immune-mediated diseases using single-cell RNA sequencing, we generated a unified, high-resolution reference of immune cell states in human disease.
Despite decades of research, our understanding of Inflammation has largely remained fragmented, studied one disease at a time and often confined to specific tissues. We set out to take a different approach: to ask whether inflammation leaves a shared, measurable fingerprint at the systems level of circulating immune cells and whether this signal could be leveraged for Diagnostics and ultimately Precision Medicine.
Blood, unlike tissue biopsies, is accessible, repeatable, and scalable, making it an ideal substrate for liquid biopsy approaches. The key question was whether it also contains sufficient biological signal to capture disease-driving inflammatory mechanisms❓
Using interpretable machine learning approaches, specifically gradient boosted decision trees (GBDT) combined with SHAP explanations, we asked whether single cells, and ultimately patients, could be classified based solely on their blood immune transcriptomes. !!! Disease-associated gene expression signatures enabled accurate classification within the study cohort, reinforcing the concept that immune cells in circulation function as “Living Biomarkers”🩸
We are now working toward a diagnostic prototype that brings these concepts closer to clinical reality. Together with hospital and industry partners, we aim to develop Foundation Models of immune cell plasticity that can operate across diseases and settings, enabling patient stratification, therapy monitoring, and outcome prediction from blood alone.
Our long-term vision is a future in which a simple blood draw provides a systems-level readout of immune health, guiding diagnosis and treatment across inflammatory diseases.
Immune cells are already doing the sensing. The challenge and opportunity is to learn how to listen. Please find the Nature Medicine Paper here:
lnkd.in/eYV7pwrN
Holger Heyn retweeted
Interact with your immune system, explore your cellular profile, & translate complex immune data into actionable health insights; powered by AI and clinical-grade science.
Discover ImmuneGPT, now fully integrated into osLifetime:
eu1.hubs.ly/H0qZDKB0
#ScienceIsWeAll #JPMNews
















